Latest Breaking News On - Patrick squiban - Page 1 : comparemela.com

Odimma Therapeutics, a biotechnology company specialized in personalized cancer immunotherapy announces a seed fundraising of €2 million in order to secure the preparation on its First-in-Man clinical

United kingdomJean marc limacherPatrick squibanEurope illkirchPascale balducchiBusiness angels networkOdimma therapeuticsCapital grand estAlsace business angelsAngels santBusiness angelsTouchlight geneticsMarc limacherBusiness officer